WILMINGTON, N.C. (WECT) - Indochine announced in a Facebook post that its owner and founder died. According to the post, the restaurant’s owner, Solange “Niki” Thompson, died Thursday, Dec. 18, ...

Niki Prongos is a twitchy, fluid mover with a quick trigger in pass protection and above-average movement skills that offer upside to develop into a future starter, but below-average play strength and ...

Don’t expect to see Nicky Hilton trading couture for confessionals anytime soon. Despite her mother, “Real Housewives of Beverly Hills” fan favorite Kathy Hilton, recently telling SiriusXM’s Page Six ...

I maintain a hold rating on Astria Therapeutics with an updated $13 target price following BioCryst's announced acquisition, expecting a 90%+ chance of deal closure by Q1 2026. The investment thesis ...

EXCLUSIVE: Actor and producer Nicholas G. Sims has signed with Asteria Artists for management. Sims will appear in the upcoming third season of Starz’s acclaimed drama P-Valley, the series created by ...

Los Angeles Dodgers pitcher Yoshinobu Yamamoto has become one of baseball’s biggest stars — and fans are now just as curious about his life off the field. In November 2024, dating rumors began ...

Oscar-winning directors Michael Govier and Will McCormack are behind the project, with the team planning an awards campaign. By Borys Kit Senior Film Writer Star Wars Shake-Up: Kathleen Kennedy Steps ...

Shares of Astria Therapeutics ATXS rallied 37.1% on Tuesday after the company signed a definitive agreement to be acquired by BioCryst Pharmaceuticals BCRX for a mix of cash and stock, representing an ...

BioCryst Pharmaceuticals (NASDAQ:BCRX) has agreed to acquire biopharmaceutical firm Astria Therapeutics (NASDAQ:ATXS) for a mix of cash and stock representing an implied value of $13.00 per Astria ...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) on Tuesday agreed to acquire Astria Therapeutics, Inc. (NASDAQ:ATXS) for a mix of cash and stock. The deal represents an implied value of $13 per Astria ...

Shares of Astria Therapeutics were significantly higher, while BioCryst's fell after the companies said BioCryst would buy Astria at a 53% premium to Astria's closing price Monday. Astria rose 36% to ...